Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Hiddensecretson Feb 05, 2021 7:57pm
471 Views
Post# 32491202

MEDV trades at (1/2 of 1 time sale) - VERY CHEAP....

MEDV trades at (1/2 of 1 time sale) - VERY CHEAP....Can anyone tell me why any company in the world that whose revenue is going to double, triple and quadruple is trading at a 1/2 of 1 times sales?

Stocks can trade upwards of 10x sales and here we trade at  0.5x sales.

Here are my calculations using only January 2021 track record:

Total tests:           73,973 * $ 96 USD per test                 $ 7,101,408 USD

In Canadian that will be at $ 1.3415:                                 9,526,539
Then we add:   Kinross                                                      2,000,000
And Columbia and real estate                                           2,000,000  (estimated)

TOTAL SALES:   January 2021                                    $ 13,526,539

PROJECT RUN RATE 2021 BASED ON JAN            $ 162,318,468   Projected sales in 2021

MARKET CAP NOW                                                         85,000,000

TRADING AT (85,000,000/162,318,468)                             .52x sales (that is 1/2 of 1x sales)

We have not included any of the covid19 disinfectant, nor additional cubes, nor blowfish, nor any other possible deal.

Let me ask you a question:    Is this too expensive for you????

Perhaps knownothing can comment....lol....

                      
MPO

<< Previous
Bullboard Posts
Next >>